| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1142ff01e0aeeeca247ceb1acf36269c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35109986fb65fc626435ac37cad4a570
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e57addc61deec021250342940d62e9c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
2000-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fec6ff38a1a6ac85c6f2f64ab95bff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f16d1964ac315521f002d21b0810dc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26f7103cd868c4e5af28b14a10bfb2a |
| publicationDate |
2001-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0134177-A2 |
| titleOfInvention |
Method of treating a viral infection using antagonists of macrophage colony stimulating factor |
| abstract |
A method is provided for treating a viral infection of a cell associated with increased production of M-CSF including contacting the cell with a concentration of M-CSF antagonist sufficient to inhibit replication of the virus. A method is also disclosed for treating a viral infection associated with increased production of macrophage colony stimulating factor (M-CSF), including administering to a subject a therapeutically effective amount of M-CSF antagonist that inhibits replication of the virus. In addition, a method is provided for treating a subject infected with an immunodeficiency virus including administering to the subject a therapeutically effective amount of anti-retroviral drug and co-administering to the subject a therapeutically effective amount of an antagonist of M-CSF. A pharmaceutical composition is provided for the treatment of a viral infection associated with an increased production of M-CSF, including a therapeutically effective amount of an M-CSF antagonist and a pharmaceutically acceptable carrier. The pharmaceutical composition may also include an anti-retroviral drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11186646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522186-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562970-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9718883-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10618967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8183207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10975153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9957327-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9765147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9079956-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8206715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982001-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10822421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11566076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8080246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9926371-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280219-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8747845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10040858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008500806-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034759-B2 |
| priorityDate |
1999-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |